(Q40473390)

20 September 2017

title

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? (English)

1 reference

drug reaction with eosinophilia and systemic symptoms

20 September 2017

main subject

1 reference

H Peyrière

1

1 reference

20 September 2017

O Dereure

2

1 reference

20 September 2017

H Breton

3

1 reference

20 September 2017

P Demoly

4

1 reference

20 September 2017

M Cociglio

5

1 reference

20 September 2017

J-P Blayac

6

1 reference

20 September 2017

D Hillaire-Buys

7

1 reference

20 September 2017

Network of the French Pharmacovigilance Centers

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

British Journal of Dermatology

20 September 2017

published in

1 reference

20 September 2017

volume

155

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

422-428

1 reference

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Dapsone hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Allergic Reaction to Allopurinol with Cross-Reactivity to Oxypurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Idiosyncratic drug reactions: the reactive metabolite syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Glutathione deficiency and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Carbamazepine-induced pseudolymphoma with CD-30 positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Drug-induced hypersensitivity syndrome in internal medicine: diagnostic and therapeutic traps. Eight observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Generalized Pustulation as a Manifestation of the Anticonvulsant Hypersensitivity Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Systemic corticosteroids in the phenytoin hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Lamotrigine overdose presenting as anticonvulsant hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Hypersensitivity reaction in a child due to lamotrigine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Minocycline pneumonitis and eosinophilia. A report on eight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

DRESS syndrome associated with nevirapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Metabolism of Lamotrigine to a Reactive Arene Oxide Intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

Anaphylaxis after rechallenge with abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07284.X

10.1111/J.1365-2133.2006.07284.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference